BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15622444)

  • 1. Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with a special emphasis on BAFF.
    Szodoray P; Jellestad S; Alex P; Zhou T; Wilson PC; Centola M; Brun JG; Jonsson R
    J Clin Immunol; 2004 Nov; 24(6):600-11. PubMed ID: 15622444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.
    Groom J; Kalled SL; Cutler AH; Olson C; Woodcock SA; Schneider P; Tschopp J; Cachero TG; Batten M; Wheway J; Mauri D; Cavill D; Gordon TP; Mackay CR; Mackay F
    J Clin Invest; 2002 Jan; 109(1):59-68. PubMed ID: 11781351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome.
    d'Arbonneau F; Pers JO; Devauchelle V; Pennec Y; Saraux A; Youinou P
    Arthritis Rheum; 2006 Jan; 54(1):115-26. PubMed ID: 16385503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren's syndrome.
    Jonsson MV; Szodoray P; Jellestad S; Jonsson R; Skarstein K
    J Clin Immunol; 2005 May; 25(3):189-201. PubMed ID: 15981083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.
    Szodoray P; Jonsson R
    Scand J Immunol; 2005 Nov; 62(5):421-8. PubMed ID: 16305638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome.
    Pontarini E; Fabris M; Quartuccio L; Cappeletti M; Calcaterra F; Roberto A; Curcio F; Mavilio D; Della Bella S; De Vita S
    Rheumatology (Oxford); 2015 Aug; 54(8):1429-34. PubMed ID: 25740829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
    Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.
    Szodoray P; Alex P; Jonsson MV; Knowlton N; Dozmorov I; Nakken B; Delaleu N; Jonsson R; Centola M
    Clin Immunol; 2005 Nov; 117(2):168-76. PubMed ID: 16126006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
    Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
    Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
    Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
    Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjögren's syndrome.
    Szodoray P; Jellestad S; Teague MO; Jonsson R
    Lab Invest; 2003 Mar; 83(3):357-65. PubMed ID: 12649336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
    Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
    Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
    Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
    Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
    Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome.
    Zeher M; Szodoray P; Gyimesi E; Szondy Z
    Arthritis Rheum; 1999 Aug; 42(8):1673-81. PubMed ID: 10446867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of Intracellular BAFF in B Cells of Sjögren's Patients Is Not Affected by Decrease of BAFFR.
    Krejsek J; Koláčková M; Lindrová I; Slezák R; Andrýs C
    Acta Medica (Hradec Kralove); 2015; 58(1):25-31. PubMed ID: 26454804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
    Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome.
    Yoshimoto K; Tanaka M; Kojima M; Setoyama Y; Kameda H; Suzuki K; Tsuzaka K; Ogawa Y; Tsubota K; Abe T; Takeuchi T
    Arthritis Res Ther; 2011; 13(5):R170. PubMed ID: 22018243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.
    Pers JO; Devauchelle V; Daridon C; Bendaoud B; Le Berre R; Bordron A; Hutin P; Renaudineau Y; Dueymes M; Loisel S; Berthou C; Saraux A; Youinou P
    Arthritis Rheum; 2007 May; 56(5):1464-77. PubMed ID: 17469105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.